PDGF-induced migration of synthetic vascular smooth muscle cells through c-Src-activated L-type Ca<sup>2+</sup> channels with full-length Ca<sub>V</sub>1.2 C-terminus

Bibliographic Information

Other Title
  • c-Srcによる全長型Ca<sub>V</sub>1.2サブユニットを有するL型Ca<sup>2+</sup>チャネルの活性化を介したPDGFによる増殖型血管平滑筋細胞の遊走

Abstract

<p>Platelet-derived growth factor (PDGF) potently induces migration of vascular smooth muscle cells (VSMC); however, molecular mechanism underlying this phenomenon remains unclear. The migration of rat aorta-derived synthetic VSMCs, A7r5, in response to PDGF was potently inhibited by a CaV1.2 channel inhibitor, nifedipine, and a Src family tyrosine kinase inhibitor, bosutinib, in a less-than-additive manner. In contractile VSMCs, the C-terminus of CaV1.2 is proteolytically cleaved into proximal and distal C-termini (PCT and DCT, respectively). Clipped DCT is noncovalently reassociated with PCT to autoinhibit the channel activity. Conversely, in synthetic A7r5 cells, full-length CaV1.2 (CaV1.2FL) is expressed much more abundantly than truncated CaV1.2. In a heterologous expression system, c-Src was bound to, phosphorylated Tyr1709 and Tyr1758 in PCT and activated CaV1.2 channels composed of CaV1.2FL significantly more efficiently than CaV1.2 (CaV1.2delta1763) or CaV1.2delta1763 plus clipped DCT. Therefore, in atherosclerotic lesions, phenotypic switching of VSMCs may facilitate pro-migratory effects of PDGF on VSMCs by suppressing posttranslational CaV1.2 modifications.</p>

Journal

Details 詳細情報について

Report a problem

Back to top